Mustang Bio, Inc. (MBIO): Total Assets
$17.59M
As of 2025-12-31
$15.61M
As of 2026-06-30
-42.5%
3-year compound annual growth
-30.7%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $17.59M | +89.0% | 2026-03-19, Balance as of period end |
| 2024-12-31 | $9.31M | -47.5% | 2026-03-19, Balance as of period end |
| 2023-12-31 | $17.74M | -80.8% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $92.42M | -26.2% | 2024-03-11, Balance as of period end |
| 2021-12-31 | $125.17M | +13.9% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $109.90M | +49.6% | 2022-03-23, Balance as of period end |
| 2019-12-31 | $73.44M | +71.8% | 2021-03-24, Balance as of period end |
| 2018-12-31 | $42.75M | -32.7% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $63.49M | +130.9% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $27.50M | n/a | 2018-03-29, Balance as of period end |
| 2015-12-31 | $0 | n/a | 2017-03-31, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Mustang Bio, Inc. (MBIO) | 2025-12-31 | $17.59M | +89.0% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $17.74M | -49.3% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $17.41M | -14.2% |
| Clene Inc. (CLNN) | 2025-12-31 | $18.13M | -33.7% |
| Lipocine Inc. (LPCN) | 2025-12-31 | $17.01M | -24.5% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $18.26M | -19.4% |
| Tempest Therapeutics, Inc. (TPST) | 2025-12-31 | $16.93M | -59.2% |
| Galmed Pharmaceuticals Ltd. (EOCN) | 2025-12-31 | $18.63M | +0.7% |
| Aditxt, Inc. (ADTX) | 2025-12-31 | $16.52M | -48.6% |
Compare MBIO, LSTA, IBO, CLNN side by side · Screen every company in Pharmaceutical Preparations ↗